Literature DB >> 365210

Dopamine agonists for negative symptoms in schizophrenia.

D J King.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 365210      PMCID: PMC1429695          DOI: 10.1111/j.1365-2125.1978.tb00882.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  A simple and reliable subclassification of chronic schizophrenia.

Authors:  J K WING
Journal:  J Ment Sci       Date:  1961-09

2.  Schizophrenia and tardive dyskinesia: is schizophrenia also a "denervation hypersensitivity"?

Authors:  R M Kapit
Journal:  Med Hypotheses       Date:  1977 Sep-Oct       Impact factor: 1.538

3.  Central dopamine turnover in schizophrenic syndromes.

Authors:  M B Bowers
Journal:  Arch Gen Psychiatry       Date:  1974-07

4.  Schizophrenia as dopamine-deficiency disease.

Authors:  G Chouinard; B D Jones
Journal:  Lancet       Date:  1978-07-08       Impact factor: 79.321

Review 5.  Bromocriptine in Parkinsonism.

Authors:  I Pearce; J M Pearce
Journal:  Br Med J       Date:  1978-05-27

6.  Double blind trial of L-dopa in chronic schizophrenia.

Authors:  F H Buchanan; R V Parton; J W Warren; E P Baker
Journal:  Aust N Z J Psychiatry       Date:  1975-12       Impact factor: 5.744

7.  Dopamine and schizophrenia.

Authors:  T J Crow; E C Johnstone; J F Deakin; A Longden
Journal:  Lancet       Date:  1976-09-11       Impact factor: 79.321

8.  Long-term treatment of parkinsonism with bromocriptine.

Authors:  D B Calne; C Plotkin; A C Williams; J G Nutt; A Neophytides; P F Teychenne
Journal:  Lancet       Date:  1978-04-08       Impact factor: 79.321

9.  Mechanism of the antipsychotic effect in the treatment of acute schizophrenia.

Authors:  E C Johnstone; T J Crow; C D Frith; M W Carney; J S Price
Journal:  Lancet       Date:  1978-04-22       Impact factor: 79.321

10.  Increased dopamine-receptor sensitivity in schizophrenia.

Authors:  F Owen; A J Cross; T J Crow; A Longden; M Poulter; G J Riley
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.